Points of Discussion:

    Community care is the Foundation of Heart Failure Management

    Are SGLT2 drugs the standard of care for CAD, CKD and Heart failure?

    Diabetics with vascular disease: SGLT2 vs GLP1? Or both

    Ischemia trial shift our understanding and approach to chest pain

    Cholesterol and the high-risk patient: New guidelines and new options

    Antiplatelet with anticoagulants in CAD secondary prevention

    Colchicine for the high-risk CAD patient